Robert J. Kammer, Director at HARROW HEALTH, INC. (HROW), sold 6,500 shares at $7.91 ($51K) on 2019-07-15, disclosed to the SEC on 2019-07-16.
Open-market sale of $51k HROW by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HROW | SELL | 2019-09-11 | $37K | — | Filing → |
| HROW | SELL | 2019-08-14 | $45K | — | Filing → |
| HROW | SELL | 2019-06-05 | $58K | — | Filing → |